1. Lifetime Incidence of CKD Stages 3-5 in the United States
Morgan E. Grams, MD, MHS, Eric K.H. Chow, MS, Dorry L. Segev, MD, PhD, Josef Coresh, MD, PhD 
American Journal of Kidney Diseases 
Volume 62, Issue 2, Pages (August 2013)
DOI: /j.ajkd
Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Markov chain model used to simulate the progression of an initially chronic kidney disease (CKD)-free individual through death or the development of CKD. Abbreviations: ICKD, 1-year probability of developing CKD; QCKD, 1-year probability of dying in an individual with CKD; QnoCKD, 1-year probability of dying prior to the development of CKD. Here, CKD is treated as a single outcome, representing the stage of interest (CKD 3a+, CKD 3b+, CKD 4+, or end-stage renal disease). Progression through CKD stages is not modeled.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

3. Figure 2
Cumulative incidence from birth by race and sex of chronic kidney disease (CKD) stage (A) 3a+, (B) 3b+, (C) 4+, and (D) end-stage renal disease (ESRD).
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

4. Figure 3
Chronic kidney disease (CKD) stage 3a+ projections by age, race, and sex, scaled by estimated 2012 US population.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions